Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activated STING in the thymic epithelium alters T cell development and selection leading to autoimmunity
Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum
Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum
View: Text | PDF
Research Article Autoimmunity Immunology

Activated STING in the thymic epithelium alters T cell development and selection leading to autoimmunity

  • Text
  • PDF
Abstract

Coatomer protein complex subunit α (COPA) syndrome is a monogenic disorder of immune dysregulation that leads to interstitial lung disease and high-titer autoantibodies. Constitutive activation of the innate immune molecule stimulator of interferon genes (STING) is centrally involved in disease. However, the mechanisms by which STING results in autoimmunity are not well understood in COPA syndrome and other STING-associated diseases. Prior studies showed a cell autonomous role for STING in thymocyte development. Single-cell data of human thymus demonstrated that STING is highly expressed in medullary thymic epithelial cells (mTECs) and at levels much greater than in T cells. Here, we show that in certain contexts, activated STING exerts a functional role in the thymic epithelium to alter thymocyte selection and predisposes to autoimmunity. In CopaE241K/+ mice, activated STING in mTECs amplified IFN signaling, impaired macroautophagy, and caused a defect in negative selection of T cell precursors. WT mice given a systemic STING agonist phenocopied the selection defect and showed enhanced thymic escape of a T cell clone targeting a self-antigen also expressed in melanoma. Our work demonstrates that STING activation in TECs shapes the T cell repertoire and contributes to autoimmunity, findings that are important for conditions that activate thymic STING.

Authors

Zimu Deng, Christopher S. Law, Santosh Kurra, Noa Simchoni, Anthony K. Shum

×

Figure 2

Activated STING in thymic stroma increases SP thymocytes.

Options: View larger image (or click on image) Download as PowerPoint
Activated STING in thymic stroma increases SP thymocytes.
(A) Left: repr...
(A) Left: representative flow plots of CD4+ and CD8+ on reconstituted thymocytes in bone marrow chimeras. Right: percentages of CD4+ SP and CD8+ SP thymocytes among the reconstituted thymocytes (WT→WT, n = 6; WT→CopaE241K/+, n = 6; WT→Stinggt/gt, n = 5; WT→CopaE241K/+/Stinggt/gt, n = 5). (B) Left: representative flow analysis of CD69 and TCR-β on reconstituted thymocytes in bone marrow chimeras. Right: percentages of CD69hi TCRβhi and CD69lo TCRβhi among the reconstituted thymocytes. (C) Percentages of CD69lo MHC-IIhi (mature stage 2) among the reconstituted CD4+ and CD8+ SP thymocytes. Flow gating strategy is in Supplemental Figure 5A. WT→WT, n = 7; WT→CopaE241K/+, n = 6; CopaE241K/+→WT, n = 6; CopaE241K/+→CopaE241K/+, n = 4; WT→Stinggt/gt, n = 4; WT→CopaE241K/+/Stinggt/gt, n = 3. Data in A–C were pooled from at least 2 independent experiments and are mean ± SD. Two-way ANOVA with Šidák’s multiple-comparison test was used for statistical analysis in A and B. One-way ANOVA and Bonferroni’s multiple-comparison test were used in C. A P value of less than 0.05 was considered statistically significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts